𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Isoeugenodilol: A vasorelaxant α/β-adrenoceptor blocker with antioxidant activity

✍ Scribed by Jwu-Lai Yeh; Tzu-Hsin Yang; Jhy-Chong Liang; Yeun-Chih Huang; Yi-Ching Lo; Jiunn-Ren Wu; Young-Tso Lin; Ing-Jun Chen

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
263 KB
Volume
51
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ferulidilol: A vasodilatory and antioxid
Ferulidilol: A vasodilatory and antioxidant adrenoceptor and calcium entry blocker, with ancillary β2-agonist activity
✍ Yeun-Chih Huang; Jwu-Lai Yeh; Bin-Nan Wu; Yi-Ching Lo; Jhy-Chong Liang; Young-Ts 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Intravenous injection of ferulidilol (0.5, 1.0, 1.5 mg kg -1 ) produced dose-dependent hypotensive and bradycardia responses in pentobarbital-anesthetized Wistar rats. Ferulidilol competitively antagonized (-)isoprenaline-induced positive inotropic and chronotropic effects of the atria and tracheal

Eugenolol: An eugenol-derived β-adrenoce
Eugenolol: An eugenol-derived β-adrenoceptor blocker with partial β2-agonist and calcium mobilization inhibition associated vasorelaxant activities
✍ Sheue-Jiun Chen; Yeun-Chih Huang; Bin-Nan Wu; Ing-Jun Chen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

The β-adrenoceptor blocking, vasorelaxant and hypotensive activities of eugenolol (1-(isopropylamino)-3-[(4-allyl-2-methoxy-)phenoxy]-2-propanol) were investigated under in vivo and in vitro conditions. In pentobarbital anesthetized rats, eugenolol (0.1, 0.5, 1.0 mg/kg, i.v.) produced a dose-depende

Labedipinedilol-A: A vanilloid-based α/β
Labedipinedilol-A: A vanilloid-based α/β-adrenoceptor blocker with calcium entry blocking and long-acting antihypertensive properties
✍ Jhy-Chong Liang; Jwu-Lai Yeh; Lien-Chai Chiang; Yu-Chiao Yang; Sheng-Hsiung Sheu 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

The combination of β-adrenoceptor blockade and vasodilator action have proved highly useful in antihypertensive therapy. Studies of the mechanisms of action of labedipinedilol-A that combine these effects within a single molecule are described in this report. Intravenous labedipinedilol-A (0.1-1.0 m